Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

NCT02605187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2018-10-16

Study results available
· View outcomes & findings →

Summary

The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage selection can optimize pain relief while minimizing related side effects. This could result in a more patient-centered care model and individualized perioperative analgesic treatment protocols based on patient's preferences, needs and expectations.

Conditions

  • Postoperative Pain

Interventions

OTHER

No choice given

Patients are randomized to getting a choice or not getting a choice. If they do not get a choice, they receive standard dose.

OTHER

Choice given

Patients are randomized to getting a choice or not getting a choice. If they do get a choice, they will receive the protocol they select.

DRUG

Ibuprofen

Ibuprofen 600mg po q6h

DRUG

Acetaminophen

Acetaminophen 650mg po q6h

DRUG

Gabapentin

Gabapentin 600mg po one time within 1 hour of delivery

DRUG

Morphine (low)

Intrathecal morphine dose 50mcg

DRUG

Morphine (med)

Intrathecal morphine dose 150mcg

DRUG

Morphine (high)

Intrathecal morphine 300mcg

Sponsors & Collaborators

Principal Investigators

  • Brendan Carvalho, MBBCh, MDCH · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-05-22
Completion
2017-05-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02605187 on ClinicalTrials.gov